series-b
Stage
2020
Founded
4
Investors
About
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers.
Explore Aktis Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.